المؤلفون: Christophe Caillat, Delphine Guilligay, Johana Torralba, Nikolas Friedrich, Jose L Nieva, Alexandra Trkola, Christophe J Chipot, François L Dehez, Winfried Weissenhorn

المصدر: eLife, Vol 10 (2021)

مصطلحات موضوعية: HIV-1, gp41, membrane fusion, LN01, 4E10, 2H10, Medicine, Science, Biology (General), QH301-705.5

وصف الملف: electronic resource

العلاقة: https://elifesciences.org/articles/65005Test; https://doaj.org/toc/2050-084XTest

الوصول الحر: https://doaj.org/article/c1f8eb01d322414cb7d10e348e2d38dcTest

المؤلفون: Caillat, Christophe, Guilligay, Delphine, Torralba, Johana, Friedrich, Nikolas, Nieva, José Luis, Trkola, Alexandra, Chipot, Christophe J., Dehez, François L., Weissenhorn, Winfried

المساهمون: European Commission, Agence Nationale de la Recherche (France), Université Grenoble Alpes, Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Eusko Jaurlaritza, Ministerio de Economía y Competitividad (España), Caillat, Christophe, Friedrich, Nikolas, Trkola, Alexandra, Chipot, Christophe J., Weissenhorn, Winfried

مصطلحات موضوعية: 2H10, 4E10, HIV-1, LN01, Gp41, Infectious diseases, Membrane fusion, Microbiology, Molecular biophysics, Structural biology, Virus

وصف الملف: application/pdf

العلاقة: #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/EC/H2020/681137; info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-095624-B-C21/ES/EL RETO DE (RE)PRODUCIR SUPERANTICUERPOS NEUTRALIZANTES DEL VIH DIRIGIDOS CONTRA MPER: UN ABORDAJE MULTIDISCIPLINAR/; info:eu-repo/grantAgreement/MINECO//BIO2015-64421-R/ES/DESARROLLO DE ANTICUERPOS ANTI-GP41 RECOMBINANTES COMO NUEVOS INHIBIDORES DE LA FUSION DEL VIH/; Publisher's version; The underlying dataset has been published as supplementary material of the article in the publisher platform at 10.7554/eLife.65005; Sí; eLife 10: e65005 (2021); http://hdl.handle.net/10261/329596Test; http://dx.doi.org/10.13039/501100003329Test; http://dx.doi.org/10.13039/501100001665Test; http://dx.doi.org/10.13039/501100011033Test; http://dx.doi.org/10.13039/501100000780Test; http://dx.doi.org/10.13039/501100003086Test; 2-s2.0-85105772575; https://api.elsevier.com/content/abstract/scopus_id/85105772575Test

الإتاحة: https://doi.org/10.7554/ELIFE.6500510.13039/50110000332910.13039/50110000166510.13039/50110001103310.13039/50110000078010.13039/501100003086Test
http://hdl.handle.net/10261/329596Test
https://api.elsevier.com/content/abstract/scopus_id/85105772575Test

المؤلفون: Caillat, Christophe, Guilligay, Delphine, Sulbaran, Guidenn, Weissenhorn, Winfried

المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017)

المصدر: ISSN: 1999-4915 ; Viruses ; https://hal.science/hal-02986465Test ; Viruses, 2020, 12 (11), pp.1210. ⟨10.3390/v12111210⟩.

مصطلحات موضوعية: HIV-1, Env, gp41, MPER, 4E10, 10E8, DH511, VRC42, LN01, PGZL1, HK20, PGT151, VRC34, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33114242; hal-02986465; https://hal.science/hal-02986465Test; https://hal.science/hal-02986465/documentTest; https://hal.science/hal-02986465/file/Caillat%20et%20al.%20Viruses.pdfTest; PUBMED: 33114242

الإتاحة: https://doi.org/10.3390/v12111210Test
https://hal.science/hal-02986465Test
https://hal.science/hal-02986465/documentTest
https://hal.science/hal-02986465/file/Caillat%20et%20al.%20Viruses.pdfTest

المؤلفون: Christophe Caillat, Delphine Guilligay, Guidenn Sulbaran, Winfried Weissenhorn

المصدر: Viruses; Volume 12; Issue 11; Pages: 1210

مصطلحات موضوعية: HIV-1, Env, gp41, MPER, 4E10, 10E8, DH511, VRC42, LN01, PGZL1, HK20, PGT151, VRC34

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: General Virology; https://dx.doi.org/10.3390/v12111210Test

الإتاحة: https://doi.org/10.3390/v12111210Test

المؤلفون: Pinto, Dora, Fenwick, Craig, Caillat, Christophe, Silacci, Chiara, Guseva, Serafima, Dehez, Francois, Chipot, Christophe, Barbieri, Sonia, Minola, Andrea, Jarrossay, David, Tomaras, Georgia, D., Shen, Xiaoying, Riva, Agostino, Tarkowski, Maciej, Schwartz, Olivier, Bruel, Timothée, Dufloo, Jérémy, Seaman, Michael, Montefiori, David, C, Lanzavecchia, Antonio, Corti, Davide, Pantaleo, Giuseppe, Weissenhorn, Winfried

المساهمون: Institute for Research in Biomedicine Ticino, Switzerland, Università della Svizzera italiana = University of Italian Switzerland (USI), Service of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois = Lausanne University Hospital Lausanne (CHUV), Laboratoire d'Enzymologie et Biochimie Structurales (LEBS), Centre National de la Recherche Scientifique (CNRS), International Center for Infectiology Research, Laboratoire de Physique et Chimie Théoriques (LPCT), Institut de Chimie - CNRS Chimie (INC-CNRS)-Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Humabs BioMed SA, Duke Human Vaccine Institute Durham, North Carolina, USA, Department of Cytomorphology, Università degli Studi di Cagliari = University of Cagliari (UniCa)-School of Medicine, Università degli Studi di Milano = University of Milan (UNIMI), Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center Boston (BIDMC), Harvard Medical School Boston (HMS)-Harvard Medical School Boston (HMS), Duke University Medical Center, Institute for Research in Biomedicine, ISMN, CNR, Roma, Institut de biologie structurale (IBS - UMR 5075 ), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes 2016-2019 (UGA 2016-2019 )-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), This work was supported by Collaboration for AIDS Vaccine Discovery grants from the Bill and Melinda Gates Foundation (OPP1114725 to G.P. and A.L. and OPP1032144 to D.C.M.). Part of the project (W.W.) has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 681137. W.W. acknowledges the Institute Universitaire de France (IUF) and the platforms of the Grenoble Instruct-ERIC center (ISBG, UMS 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB). Platform access was supported by FRISBI (ANR-10-INBS-05-02) and GRAL, a project of the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003). O.S. acknowledges funding from the Institut Pasteur, the ANRS, the Vaccine Research Institute and the Gilead HIV cure program., ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017), European Project: 681137,H2020,H2020-PHC-2015-single-stage_RTD,EAVI2020(2015)

المصدر: ISSN: 1931-3128 ; Cell Host and Microbe ; https://hal.science/hal-02336304Test ; Cell Host and Microbe, 2019, 26 (5), pp.623-637.e8. ⟨10.2139/ssrn.3416843⟩.

مصطلحات موضوعية: 10E8, 4E10, Env, HIV-1, LN01, MPER, broadly neutralizing antibody, gp41, membrane interaction, [SDV.BBM.BP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biophysics

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31653484; info:eu-repo/grantAgreement//681137/EU/European AIDS Vaccine Initiative 2020/EAVI2020; hal-02336304; https://hal.science/hal-02336304Test; https://hal.science/hal-02336304/documentTest; https://hal.science/hal-02336304/file/1-s2.0-S1931312819304834-main.pdfTest; PUBMED: 31653484

الإتاحة: https://doi.org/10.2139/ssrn.3416843Test
https://hal.science/hal-02336304Test
https://hal.science/hal-02336304/documentTest
https://hal.science/hal-02336304/file/1-s2.0-S1931312819304834-main.pdfTest

المؤلفون: Pinto D., Fenwick C., Caillat C., Silacci C., Guseva S., Dehez F., Chipot C., Barbieri S., Minola A., Jarrossay D., Tomaras G. D., Shen X., Riva A., Tarkowski M., Schwartz O., Bruel T., Dufloo J., Seaman M. S., Montefiori D. C., Lanzavecchia A., Corti D., Pantaleo G., Weissenhorn W.

المساهمون: D. Pinto, C. Fenwick, C. Caillat, C. Silacci, S. Guseva, F. Dehez, C. Chipot, S. Barbieri, A. Minola, D. Jarrossay, G.D. Tomara, X. Shen, A. Riva, M. Tarkowski, O. Schwartz, T. Bruel, J. Dufloo, M.S. Seaman, D.C. Montefiori, A. Lanzavecchia, D. Corti, G. Pantaleo, W. Weissenhorn

مصطلحات موضوعية: 10E8, 4E10, broadly neutralizing antibody, Env, gp41, HIV-1, LN01, membrane interaction, MPER, AIDS vaccine, amino acid sequence, animal, antibodies, neutralizing, cell line, disease models, female, HEK293 Cell, HIV antibodie, HIV envelope protein gp41, human, mice, transgenic, protein domains, Settore MED/17 - Malattie Infettive

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31653484; info:eu-repo/semantics/altIdentifier/wos/WOS:000496264400011; volume:26; issue:5; firstpage:623; lastpage:637.e8; numberofpages:24; journal:CELL HOST & MICROBE; http://hdl.handle.net/2434/908317Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85074522793

الإتاحة: https://doi.org/10.1016/j.chom.2019.09.016Test
http://hdl.handle.net/2434/908317Test

المؤلفون: Delphine Guilligay, Winfried Weissenhorn, Guidenn Sulbaran, Christophe Caillat

المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017)

المصدر: Viruses
Viruses, MDPI, 2020, 12 (11), pp.1210. ⟨10.3390/v12111210⟩
Viruses, Vol 12, Iss 1210, p 1210 (2020)
Viruses, 2020, 12 (11), pp.1210. ⟨10.3390/v12111210⟩

مصطلحات موضوعية: 0301 basic medicine, Vaccine research, Env, viruses, lcsh:QR1-502, PGZL1, Review, HIV Antibodies, Gp41, VRC42, Epitope, lcsh:Microbiology, 03 medical and health sciences, Epitopes, Mice, 0302 clinical medicine, 10E8, PGT151, 4E10, Virology, Animals, Humans, chemistry.chemical_classification, AIDS Vaccines, biology, [SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM], DH511, virus diseases, Antibodies, Neutralizing, gp41, HIV Envelope Protein gp41, 3. Good health, VRC34, MPER, Heptad repeat, 030104 developmental biology, Infectious Diseases, chemistry, Mutation, biology.protein, HIV-1, HK20, LN01, Antibody, Glycoprotein, 030217 neurology & neurosurgery, Hiv 1 gp41, Fusion peptide

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284721136112255e384e00afd8132bbdTest
https://hal.archives-ouvertes.fr/hal-02986465/documentTest

المؤلفون: Christophe Chipot, Timothée Bruel, Georgia D. Tomaras, Antonio Lanzavecchia, Dora Pinto, David C. Montefiori, Giuseppe Pantaleo, Winfried Weissenhorn, Sonia Barbieri, Agostino Riva, Craig Fenwick, Davide Corti, Maciej Tarkowski, Christophe Caillat, Olivier Schwartz, David Jarrossay, Andrea Minola, Michael S. Seaman, Jérémy Dufloo, Chiara Silacci, François Dehez, Serafima Guseva, Xiaoying Shen

المساهمون: Institute for Research in Biomedicine [Ticono, Suisse], Université de Lausanne = University of Lausanne (UNIL), Institut de biologie structurale (IBS - UMR 5075 ), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Laboratoire de Physique et Chimie Théoriques (LPCT), Institut de Chimie du CNRS (INC)-Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Department of Physics [Illinois at Urbana-Champaign, USA], University of Illinois at Urbana-Champaign [Urbana], University of Illinois System-University of Illinois System, Institute for Biomedicine [Bolzano, Italy] (Eurac Research), Affiliated Institute of the University of Lübeck, Humabs BioMed SA, Duke Human Vaccine Institute [Durham, North Carolina, USA], Université Paris Diderot - Paris 7 (UPD7), Luigi Sacco University Hospital [Milan], Rheumatology Unit, Milano (ASST Fatebenefratelli-Sacco), Virus et Immunité - Virus and immunity, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Vaccine Research Institute (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Sorbonne Paris Cité (USPC), Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center [Boston] (BIDMC), Harvard Medical School [Boston] (HMS)-Harvard Medical School [Boston] (HMS), Duke University Medical Center, Institute for Research in Biomedicine, ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017), European Project: 681137,H2020,H2020-PHC-2015-single-stage_RTD,EAVI2020(2015), Université de Lausanne (UNIL), Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS), Duke Human Vaccine Institute, Duke School of Medicine

المصدر: Cell Host and Microbe
Cell Host and Microbe, Elsevier, 2019, 26 (5), pp.623-637.e8. ⟨10.1016/j.chom.2019.09.016⟩
Cell Host & Microbe
'Cell Host & Microbe ', vol: 26, pages: 623-637 (2019)

مصطلحات موضوعية: Env, education, Mice, Transgenic, HIV Antibodies, Gp41, Microbiology, Neutralization, Epitope, Article, Cell Line, broadly neutralizing antibody, 03 medical and health sciences, Mice, 0302 clinical medicine, 10E8, Protein Domains, 4E10, Virology, Animals, Humans, membrane interaction, Amino Acid Sequence, 030304 developmental biology, AIDS Vaccines, 0303 health sciences, biology, Germinal center, Fusion protein, Antibodies, Neutralizing, gp41, Transmembrane protein, HIV Envelope Protein gp41, 3. Good health, Cell biology, MPER, [SDV.BBM.BP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biophysics, Disease Models, Animal, HEK293 Cells, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, biology.protein, HIV-1, [SDV.IMM]Life Sciences [q-bio]/Immunology, Parasitology, Paratope, Female, LN01, Antibody, 030217 neurology & neurosurgery

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::937bd9cdd80f69df3c741a3fda463dadTest
https://hal.archives-ouvertes.fr/hal-02335126/file/1-s2.0-S1931312819304834-main.pdfTest

المؤلفون: Christophe Chipot, Winfried Weissenhorn, Antonio Lanzavecchia, Georgia D. Tomaras, Craig Fenwick, Serafima Guseva, Maciej Tarkowski, Dora Pinto, Chiara Silacci, Christophe Caillat, Sonia Barbieri, David C. Montefiori, Andrea Minola, Agostino Riva, Timothée Bruel, Jérémy Dufloo, Xiaoying Shen, Giuseppe Pantaleo, Olivier Schwartz, David Jarrossay, Michael S. Seaman, François Dehez, Davide Corti

المساهمون: Institute for Research in Biomedicine [Ticino, Switzerland], Università della Svizzera italiana = University of Italian Switzerland (USI), Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Laboratoire d'Enzymologie et Biochimie Structurales (LEBS), Centre National de la Recherche Scientifique (CNRS), International Center for Infectiology Research, Laboratoire de Physique et Chimie Théoriques (LPCT), Institut de Chimie du CNRS (INC)-Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Humabs BioMed SA, Duke Human Vaccine Institute [Durham, North Carolina, USA], Department of Cytomorphology, Università degli Studi di Cagliari = University of Cagliari (UniCa)-School of Medicine, Università degli Studi di Milano = University of Milan (UNIMI), Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Vaccine Research Institute [Créteil, France] (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), Beth Israel Deaconess Medical Center, Beth Israel Deaconess Medical Center [Boston] (BIDMC), Harvard Medical School [Boston] (HMS)-Harvard Medical School [Boston] (HMS), Duke University Medical Center, Institute for Research in Biomedicine, ISMN, CNR, Roma, Institut de biologie structurale (IBS - UMR 5075 ), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), This work was supported by Collaboration for AIDS Vaccine Discovery grants from the Bill and Melinda Gates Foundation (OPP1114725 to G.P. and A.L. and OPP1032144 to D.C.M.). Part of the project (W.W.) has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement no. 681137. W.W. acknowledges the Institute Universitaire de France (IUF) and the platforms of the Grenoble Instruct-ERIC center (ISBG, UMS 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB). Platform access was supported by FRISBI (ANR-10-INBS-05-02) and GRAL, a project of the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003). O.S. acknowledges funding from the Institut Pasteur, the ANRS, the Vaccine Research Institute and the Gilead HIV cure program., ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017), European Project: 681137,H2020,H2020-PHC-2015-single-stage_RTD,EAVI2020(2015), Virus et Immunité - Virus and immunity, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Vaccine Research Institute (VRI), Institute for Biomedicine [Bolzano, Italy] (Eurac Research), Affiliated Institute of the University of Lübeck, Duke Human Vaccine Institute, Duke School of Medicine, School of Medicine-University of Cagliar, Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Centre National de la Recherche Scientifique (CNRS)

المصدر: Cell Host and Microbe
Cell Host and Microbe, 2019, 26 (5), pp.623-637.e8. ⟨10.2139/ssrn.3416843⟩
Cell Host and Microbe, Elsevier, 2019, 26 (5), pp.623-637.e8. ⟨10.2139/ssrn.3416843⟩

مصطلحات موضوعية: Env, Gp41, Epitope, Neutralization, broadly neutralizing antibody, 10E8, 4E10, 0502 economics and business, membrane interaction, 050207 economics, 050208 finance, biology, 05 social sciences, Germinal center, Fusion protein, gp41, Transmembrane protein, 3. Good health, Cell biology, MPER, [SDV.BBM.BP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biophysics, biology.protein, HIV-1, Paratope, LN01, Antibody

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::533890f9283871e3e59dd6af374e5b41Test
https://hal.science/hal-02336304/documentTest

مصطلحات الفهرس: 2H10, 4E10, HIV-1, LN01, Gp41, Infectious disease, Membrane fusion, Microbiology, Molecular biophysics, Structural biology, Virus, artículo

URL: http://hdl.handle.net/10261/329596Test
https://api.elsevier.com/content/abstract/scopus_id/85105772575Test
Publisher's version
The underlying dataset has been published as supplementary material of the article in the publisher platform at 10.7554/eLife.65005
Sí
info:eu-repo/grantAgreement/EC/H2020/681137
info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-095624-B-C21/ES/EL RETO DE (RE)PRODUCIR SUPERANTICUERPOS NEUTRALIZANTES DEL VIH DIRIGIDOS CONTRA MPER: UN ABORDAJE MULTIDISCIPLINAR
info:eu-repo/grantAgreement/MINECO//BIO2015-64421-R/ES/DESARROLLO DE ANTICUERPOS ANTI-GP41 RECOMBINANTES COMO NUEVOS INHIBIDORES DE LA FUSION DEL VIH